AMAG Pharma (AMAG) Shares Rally Sharply Following Ladenburg Upgrade

Article Stock Quotes (1) Comments (0)

Shares of AMAG Pharmaceuticals (NASDAQ: AMAG) just jumped very sharply in mid-day trade Thursday morning following an intraday upgrade from Ladenburg Thalmann's Juan Sanchez. The analyst now rates the stock a Buy, up from Neutral previously. Sanchez set a new $15 price target.

AMAG shares are now up 4 percent to $13. Sanchez's new price target represents potential upside of about 15 percent.

For an analyst ratings summary and ratings history on AMAG Pharmaceuticals click here. For more ratings news on AMAG Pharmaceuticals click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
• Baird Upgrades Ball Corp (BLL) to Outperform
• UPDATE: BofA/Merrill Lynch Downgrades Cliffs Natural Resources (CLF) to Underperform

Create E-mail Alert Related Categories

Upgrades

Related Entities

Ladenburg Thalmann Financial Services

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?